Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPRAISE: Apixaban in Acute Coronary Syndrome
NCT00313300Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of apixaban in acute coronary syndrome (ACS), sponsored by Bristol Myers Squibb. Started May 2006; status: completed.
02
Drugs
apixaban
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00313300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313300.